Nirogy Therapeutics
Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therapeutic solutions for cancer and autoimmune diseases.
2-10 employees · est. 2013
Therabene
Pioneering PROTAC Molecules for Cancer and Autoimmune Disease Treatment with Collaborative Vision.
est. 2020
Nirogy Therapeutics is the older company (2013 vs 2020).
Side-by-Side Comparison
| Metric | Nirogy Therapeutics | Therabene |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2020 |
| Headquarters | ||
| Headquarters | Not tracked yet | Not tracked yet |
| Employees | ||
| Employees | 2-10 | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Debt Financing |
| Total Funding | ||
| Total Funding | $18.50M | $50.00K |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Small Molecules, Cellular Transporters, Tumor Microenvironment, Metabolic Pathways, Immune Pathways, Oncology, Cancer Treatment, Autoimmune Diseases, Therapeutic Solutions, Novel Therapeutics, Drug Development, Platform Programs, Disease Pathways | PROTAC Molecules, Cancer Treatment, Autoimmune Disease Treatment, Collaborative Vision, Dr. Mario DiPaola, Pharmaceutical Industry, Biopharmaceutical Industry, Biotech Industry, Academic Research Institutions, Clinical Research Institutions, Partnerships, Disease-specific Assets, Biotech Collaborations, Specialized Drug Development |
| Website | ||
| Website | nirogytx.com | therabene.com |
About Nirogy Therapeutics
Nirogy Therapeutics is a cutting-edge biotechnology venture, making waves in the Biopharma and Biotechnology sectors since its inception in 2013. The company's core mission, encapsulated in its slogan, "Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therape...
About Therabene
Therabene is a biotechnology firm founded in 2020, specializing in the development of PROTAC molecules for addressing cancer and autoimmune diseases. Led by experienced executive Dr. Mario DiPaola, with a notable 25-year career in the biotechnology and pharmaceutical sectors, the company emphasizes...
We will tell you when either one moves
BounceWatch watches Nirogy Therapeutics and Therabene for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nirogy Therapeutics and Therabene — by email.
Frequently Asked Questions
Compare Nirogy Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nirogy Therapeutics on 2 Apr 2026, and Therabene on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
